463
Participants
Start Date
March 23, 2015
Primary Completion Date
February 28, 2018
Study Completion Date
August 23, 2021
Niraparib
GSK Investigational Site, New York
GSK Investigational Site, Lake Success
GSK Investigational Site, Jamaica
GSK Investigational Site, East Setauket
GSK Investigational Site, Wynnewood
GSK Investigational Site, Baltimore
GSK Investigational Site, Durham
GSK Investigational Site, Atlanta
GSK Investigational Site, West Palm Beach
GSK Investigational Site, Tampa
GSK Investigational Site, Nashville
GSK Investigational Site, Indianapolis
GSK Investigational Site, Ann Arbor
GSK Investigational Site, Indianapolis
GSK Investigational Site, Minneapolis
GSK Investigational Site, Rochester
GSK Investigational Site, Chicago
GSK Investigational Site, Chicago
GSK Investigational Site, Springfield
GSK Investigational Site, New Orleans
GSK Investigational Site, Covington
GSK Investigational Site, Oklahoma City
GSK Investigational Site, Dallas
GSK Investigational Site, Tyler
GSK Investigational Site, Fort Worth
GSK Investigational Site, The Woodlands
GSK Investigational Site, San Antonio
GSK Investigational Site, Austin
GSK Investigational Site, Phoenix
GSK Investigational Site, Chandler
GSK Investigational Site, Tucson
GSK Investigational Site, Los Angeles
GSK Investigational Site, Los Angeles
GSK Investigational Site, Duarte
GSK Investigational Site, Burbank
GSK Investigational Site, Santa Barbara
GSK Investigational Site, San Francisco
GSK Investigational Site, Tacoma
GSK Investigational Site, Spokane
GSK Investigational Site, Stanford
GSK Investigational Site, New Haven
GSK Investigational Site, Boston
GSK Investigational Site, Boston
GSK Investigational Site, Burlington
GSK Investigational Site, Hackensack
GSK Investigational Site, Morristown
GSK Investigational Site, Medford
GSK Investigational Site, Providence
GSK Investigational Site, Calgary
GSK Investigational Site, Toronto
GSK Investigational Site, Montreal
GSK Investigational Site, Montreal
GSK Investigational Site, Montreal
GSK Investigational Site, Montreal
GSK Investigational Site, Sherbrooke
Collaborators (1)
Facing Our Risk of Cancer Empowered
OTHER
Myriad Genetics, Inc.
INDUSTRY
Tesaro, Inc.
INDUSTRY